Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
US4849416A · kind A · utility
8Cited by
3References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 1988 |
| Grant date | Jul 18, 1989 |
| Priority date | — |
| Expiry date | Jul 25, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are pharmaceutical compositions containing certain heterocylcic sulphonamido azo compounds for enhancing oxygen availability to mammalian tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.